Pro-Bio

GenScript ProBio is a leading global Contract Development and Manufacturing Organization (CDMO) that provides end-to-end solutions for biologics and advanced therapies. The company offers a comprehensive suite of services including antibody drug discovery, process development, and large-scale GMP manufacturing. Its expertise covers a wide range of modalities, such as monoclonal antibodies, bispecifics, antibody-drug conjugates (ADCs), and cell and gene therapy products like plasmid DNA and viral vectors. GenScript ProBio utilizes proprietary technology platforms, such as its high-efficiency cell line development and single B cell screening, to accelerate drug development timelines for its clients. With state-of-the-art facilities in China and a global presence in the United States and Europe, the company supports biotech and pharmaceutical partners from the pre-clinical stage through to commercialization.